Closed · W81XWH-22-MRP-IA · CFDA 12.420 · Discretionary

DoD Melanoma, Idea Award

Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.

Varies
Award range
Closed
Status
October 5, 2022
Close date
13
Expected awards

The verdict

DoD Melanoma, Idea Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 13 expected awards. Future funding cycles may be published under the same CFDA number.

Varies
award range
Closed
application status
13
expected awards
12.420
CFDA program

Opportunity snapshot. This Grants.gov announcement - DoD Melanoma, Idea Award - is cataloged under number W81XWH-22-MRP-IA and tied to CFDA assistance listing 12.420, posted by Defense Health Agency Contracting Activity - DHACA. Grants.gov currently shows the opportunity as closed, first posted on June 1, 2022 and last updated on October 3, 2022. The funding category is Discretionary, delivered as a grant.

Award economics. The award range on file is Varies by applicant. The agency has projected $10.4 million in total estimated funding for this announcement. It expects to issue 13 awards. If the agency funds the expected 13 awards from the $10.4 million estimated pool, the average award works out to roughly $800,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on October 5, 2022. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

Varies by applicant

Close Date

October 5, 2022

Posted

June 1, 2022

Est. Total Funding

$10,400,000

Expected Awards

13

Instrument

Grant

Description

The FY22 MRP Idea Award supports innovative, untested, exploratory, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods that are responsive to the FY22 MRP Challenge Statement and address at least one of the FY22 MRP Focus Areas in Section II.A.1. The advancement of knowledge in melanoma research, patient care, and/or treatment options in the Military Health System is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public.The purpose of the Idea Award is to generate novel research avenues for investigation; therefore, novelty and innovation should be key aspects of the proposed research. Research supported by the Idea Award must introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. The proposed project can be exploratory, hypothesis-driven or hypothesis-generating research but must be based on a strong scientific rationale and a well-developed study design and plan of analysis.The Idea Award is not intended to expand or extend previously published findings or continue an established line of research. Incremental advances, the next logical step, or merely switching the object or method of inquiry from one cancer to another cancer is not considered innovative.

Eligibility

Grants.gov lists this opportunity under eligibility category code 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org

Key Dates

Posted June 1, 2022
Close Date October 5, 2022
Archive Date November 4, 2022
Last Updated October 3, 2022

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "DoD Melanoma, Idea Award", offered by Defense Health Agency Contracting Activity - DHACA. It is associated with CFDA program 12.420. The FY22 MRP Idea Award supports innovative, untested, exploratory, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods that are responsive to the FY22 MRP Challenge Statem...
Is this opportunity still open?
No, this opportunity is closed. It closed on October 5, 2022. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is Varies by applicant. Total estimated funding: $10,400,000. Expected number of awards: 13.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants